Edaravone (Radicava)

Edaravone (Radicava) is a medication used to treat amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. It works as an antioxidant, meaning it helps protect nerve cells from damage caused by oxidative stress—a type of cell injury linked to ALS progression. By reducing this damage, Edaravone may slow the decline of physical function in some patients. It is administered through intravenous infusions, typically over a short period, and is prescribed as part of a comprehensive treatment plan to help manage symptoms and potentially extend quality of life.